Forschungsprojekte und Publikationen der German Breast Group
Die German Breast Group erforscht Brustkrebs und setzt dafür selbst entwickelte Studienkonzepte um.
Mit zusätzlichen wissenschaftlichen Forschungsprojekten wollen wir weitere Erkenntnisse über die Krankheit gewinnen.
Neuste Forschungsnachrichten
-
30.06.2022 June 2022: Pregnancy does not impact the effectiveness of chemotherapy for breast cancer.
We are pleased to inform you that outcome of pregnant breast cancer patients treated with chemotherapy versus non-pregnant controls has been published in European Journal of Cancer
-
31.05.2022 May 2022: Effect of denosumab added to 2 different nab-paclitaxel regimens as neoadjuvant therapy for primary breast cancer – results from GeparX trial
We are pleased to inform you that primary results from GeparX trial have been published in JAMA Oncology.
-
24.05.2022 Ovarian Toxicity Assessment
In a paper in "The Breast" we discuss the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials.
-
23.05.2022 Ergebnisse zur Brustkrebs in der Schwangerschaft
Neue Daten zum Überleben von Brustkrebspatientinnen mit Chemotherapie während der Schwangerschaft
-
12.05.2022 GBG Research at ASCO 2022
We are happy to present our research at the ASCO Annual meeting June 2022.